Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
$54.09
+0.8%
$54.64
$47.56
$55.74
$1.99B0.62260,575 shs110,153 shs
Hemostemix Inc. stock logo
HEM
Hemostemix
C$0.05
-9.1%
C$0.07
C$0.05
C$0.18
C$4.49M0.5540,392 shs20,000 shs
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
C$0.45
+7.1%
C$0.43
C$0.35
C$0.66
C$50.64M0.8265,381 shs261,352 shs
Optec International, Inc. stock logo
OPTI
Optec International
$0.00
$0.00
$0.00
$0.00
$43KN/A41.41 million shs13.91 million shs
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
$11.20
+0.2%
$11.10
$10.52
$11.92
$242.14M-0.0158,374 shs98,478 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
+0.60%-0.35%-3.28%+1.38%+7.11%
Hemostemix Inc. stock logo
HEM
Hemostemix
0.00%-9.09%-23.08%-33.33%-67.74%
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
+13.51%+12.00%+6.33%+7.69%-30.00%
Optec International, Inc. stock logo
OPTI
Optec International
+3.23%-11.11%+6.67%+220.00%+700.00%
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
0.00%+0.09%+0.72%+1.45%+6.27%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
N/AN/AN/AN/AN/AN/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
N/AN/AN/AN/AN/AN/AN/AN/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
0.00
N/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
N/AN/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
N/AN/AN/AN/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
N/AN/AN/AN/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
N/AN/AC$0.00 per share10.77C($0.08) per shareN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
C$25.87M1.96C$0.05 per share8.93C$0.25 per share1.80
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/A$0.40 per share28.09($0.64) per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
N/AN/A17.21N/AN/AN/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
-C$3.17M-C$0.04N/AN/AN/AN/A-165.67%4/23/2024 (Estimated)
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
-C$16.96M-C$0.17N/AN/A-65.57%-47.87%-15.68%4/25/2024 (Estimated)
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/A0.00N/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
$11.44MN/A0.00N/AN/A-65.59%5.02%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
$1.082.00%N/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
N/AN/AN/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
N/AN/AN/AN/AN/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
N/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
N/A
0.25
0.48
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
71.36
1.52
1.11
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/A
0.22
0.22

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
N/A36.80 millionN/ANot Optionable
Hemostemix Inc. stock logo
HEM
Hemostemix
N/A89.79 millionN/ANot Optionable
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
249112.54 millionN/ANot Optionable
Optec International, Inc. stock logo
OPTI
Optec International
111.65 millionN/ANot Optionable
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/A21.62 million17.30 millionNot Optionable

AOR, RENE, HEM, NSCI, and OPTI Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

iShares Core Growth Allocation ETF logo

iShares Core Growth Allocation ETF

NYSEARCA:AOR
iShares Growth Allocation ETF, formerly iShares S&P Growth Allocation Fund (the Fund), is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Target Risk Growth Index (the Growth Allocation Index). The Growth Allocation Index seeks to measure the performance of an asset allocation strategy targeted to a growth-focused risk profile. The Fund is designed for investors seeking moderate capital appreciation and opportunity for current income and capital preservation. The Fund's investment advisor is BlackRock Fund Advisors.
Hemostemix logo

Hemostemix

CVE:HEM
Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia in Canada and the United States. The company is also developing various types of cell products, such as synergetic cell populations, neural cell precursors, and cardiomyocyte cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.
Nanalysis Scientific logo

Nanalysis Scientific

CVE:NSCI
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.
Optec International logo

Optec International

OTCMKTS:OPTI
Optec International, Inc. engages in selling and marketing optimized fuel maximizer units in North America and internationally. It markets optimized fuel maximizer for passenger vehicles, intermediate/medium duty trucks, off-road equipment, generator systems, heavy duty diesel on-road vehicles, and transportation refrigeration units. The company was formerly known as Green Meadow Products, Inc. and changed its name to Optec International, Inc. in August 2017. Optec International, Inc. was founded in 2012 and is based in Carlsbad, California.
Cartesian Growth Co. II logo

Cartesian Growth Co. II

NASDAQ:RENE
Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.